Kits (3)
Launched (2)In Research (1)
Human (3)
- (3)
- (3)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
- | Human IL-23 ELISA Kit | |||||
- | Human IL-23 Detection Kit (Flow Cytometry Bead Assay) | |||||
AI Compatible FRT-P010 | - | Human IL-23 / IL-23R Inhibitor Screening Kit (TR-FRET) |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Etoposide phosphate | BMY-40481 | Approved | Bristol-Myers Squibb Company | Etopophos | United States | Lymphoma, Non-Hodgkin; Multiple Myeloma; Testicular Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Hodgkin Disease; Small Cell Lung Carcinoma | Cheplapharm Arzneimittel Gmbh | 1996-05-17 | Lung Neoplasms; Neoplasms, Plasma Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma, Ewing; Brain Neoplasms; Lymphoma, Follicular; Testicular Neoplasms; Lymphoma; Germinoma; Neoplasms, Gonadal Tissue; Breast Neoplasms; Lymphoma, Non-Hodgkin; Thrombocytopenia; Burkitt Lymphoma; Carcinoma, Non-Small-Cell Lung; Myelodysplastic-Myeloproliferative Diseases; Neoplasms, Germ Cell and Embryonal; Uterine Cervical Neoplasms; Neoplasm Metastasis; Neoplasms; Solid tumours; Ovarian Neoplasms; Kidney Neoplasms; Neutropenia; Plasmacytoma; Myelodysplastic Syndromes; Small Cell Lung Carcinoma; Hodgkin Disease; Leukemia; Myeloproliferative Disorders; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Multiple Myeloma; Central Nervous System Neoplasms; Adrenocortical Carcinoma; Neuroblastoma; Sarcoma | Details |

BettinastraBe 30, 60325 Frankfurt am Main



